Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of inflammatory bowel disease.

Novartis Foundation symposium - 1 Jan 2004

Kelleher Dermot, Farrell Richard, McManus Ross

Abstract excerpt

Therapeutic outcome in inflammatory bowel disease has traditionally been related to disease activity. Recent data suggest that individual differences in drug disposition and metabolism, some of which are genetically determined, may play a significant role in the outcome of therapy for inflammatory diseases. Polymorphisms in the thiopurine methyl transferase gene (TPMT) are known to influence the outcome of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Methyltransferases
Share to Receptors, Glucocorticoid
Share to Steroids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ATP Binding Cassette Transporter, Subfamily B, Member 1

Share to Azathioprine

Share to Gastrointestinal Agents

Share to Inflammatory Bowel Diseases

Share to Infliximab

Source

Identifiers

PMID: 15669633

Genes

TPMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of inflammatory bowel disease.PMID 15669633Read ↗

Pharmacogenetics of Inflammatory Bowel DiseaseSemantic proximity Read ↗

Pharmacogenetics of inflammatory bowel disease.Semantic proximity Read ↗

Review article: interactions between genotype and response to therapy in inflammatory bowel diseases.Semantic proximity Read ↗

Pharmacogenetics of treatments for inflammatory bowel diseaseSemantic proximity Read ↗

Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.Semantic proximity Read ↗

Role of genetics in prediction of disease course and response to therapy.Semantic proximity Read ↗

Pharmacogenetics in inflammatory bowel diseaseSemantic proximity Read ↗

Pharmacogenetics of Thiopurines in Inflammatory Bowel DiseaseSemantic proximity Read ↗

Update on thiopurine pharmacogenetics in inflammatory bowel disease.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics in rheumatology.Semantic proximity Read ↗

The genetics of inflammatory bowel disease: diagnostic and therapeutic implications.Semantic proximity Read ↗

Review article: thiopurines in inflammatory bowel disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.